N-(2-hydroxyphenyl)butanamide | 28033-54-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N-(2-hydroxyphenyl)butanamide
• 英文别名: butyric acid-(2-hydroxy-anilide)；2-Butyrylamino-phenol；Buttersaeure-(2-hydroxy-anilid)；butyramidophenol
• CAS: 28033-54-7
• 化学式: C₁₀H₁₃NO₂
• mdl: MFCD00462980
• 分子量: 179.219
• InChiKey: KIUGSVWAFHJWDU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  49.3
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  N-(2-hydroxyphenyl)butanamide 在 四(三苯基膦)钯 N-甲基吡咯烷酮 、 copper(l) iodide 、 potassium tert-butylate 、 四丁基碘化铵 、 三乙胺 作用下， 以 二氯甲烷 、 乙腈 为溶剂， 反应 9.0h， 生成 2-丙基-1H-吲哚
  参考文献：
  名称：

  Chemistry of aminophenols. Part 1: Remarkable additive effect on Sonogashira cross-coupling of 2-carboxamidoaryl triflates and application to novel synthesis of indoles

  摘要：

  A novel and general synthesis of indoles has been established by utilizing 2-aminophenols as the starting materials. The key step is a modified Pd(0)-Cu(I)-catalyzed cross-coupling of 1-alkynes with 2-carboxamidoaryl triflates in the presence of n-Bu4NI as the additive. The 2-alkynylanilides obtained were subjected to an alkoxide-mediated cyclization to provide a number of indole containing compounds possessing substituents at the C2, C4, C5, and/or C6 position(s) in good overall yields. (C) 2001 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0040-4039(01)00965-0
• 作为产物：
  描述：

  1-丁酰氨基-2-苯基乙酰氧基-苯 在 氢氧化钾 作用下， 生成 N-(2-hydroxyphenyl)butanamide
  参考文献：
  名称：

  ACYL DERIVATIVES OF ORTHO-AMINOPHENOL. VI

  摘要：

  DOI：

  10.1021/ja01354a023

文献信息

• <i>N</i>-Acyl-<i>N</i>-(4-chlorophenyl)-4-nitrobenzenesulfonamides: highly selective and efficient reagents for acylation of amines in water
  作者：Sara Ebrahimi、Safoura Saiadi、Simin Dakhilpour、Seyed Nezamoddin Mirsattari、Ahmad Reza Massah

  DOI：10.1515/znb-2015-0076

  日期：2016.2.1

  been developed as chemoselective N-acylation reagents. Selective protection of primary amines in the presence of secondary amines, acylation of aliphatic amines in the presence of aryl amines, and monofunctionalization of primary-secondary diamines as well as selective N-acylation of amino alcohols using these reagents are described. All of the acylation reactions were carried out in water as a green

  摘要 多种 N-酰基-N-(4-氯苯基)-4-硝基苯磺酰胺 (1a-e) 在无溶剂条件下由 4-氯苯胺在一锅中合成，并已被开发为化学选择性 N-酰化试剂。描述了在仲胺存在下伯胺的选择性保护、芳胺存在下脂肪胺的酰化、伯仲二胺的单官能化以及使用这些试剂的氨基醇的选择性 N-酰化。所有酰化反应均在作为绿色溶剂的水中进行。这些酰化试剂的高稳定性和易于制备是该方法的其他优点。
• Carboxamide derivatives as therapeutic agents
  申请人：——

  公开号：US20020193432A1

  公开（公告）日：2002-12-19

  This invention provides certain compounds, methods of their preparation, pharmaceutical compositions comprising the compounds, and their use in treating human or animal disorders. The compounds of the invention are useful as modulators of the interaction between the receptor for advanced glycated end products (RAGE) and its ligands, such as advanced glycated end products (AGEs), S100/calgranulin/EN-RAGE, &bgr;-amyloid and amphoterin, and for the management, treatment, control, or as an adjunct treatment for diseases in humans caused by RAGE. Such diseases or disease states include acute and chronic inflammation, the development of diabetic late complications such as increased vascular permeability, nephropathy, atherosclerosis, and retinopathy, the development of Alzheimer's disease, erectile dysfunction, and tumor invasion and metastasis.

  这项发明提供了某些化合物、其制备方法、包括这些化合物的药物组合物以及它们在治疗人类或动物疾病中的用途。该发明的化合物可用作调节高级糖基化终产物受体（RAGE）与其配体之间相互作用的调节剂，这些配体包括高级糖基化终产物（AGEs）、S100/calgranulin/EN-RAGE、β-淀粉样蛋白和amphoterin，用于管理、治疗、控制或作为辅助治疗人类因RAGE引起的疾病。这些疾病或疾病状态包括急性和慢性炎症、糖尿病后期并发症的发展，如增加的血管通透性、肾病、动脉粥样硬化和视网膜病变，阿尔茨海默病的发展、勃起功能障碍以及肿瘤侵袭和转移。
• Iron(III)‐Mediated Nucleophilic Halogenation of Phenols Using an Amido Directing Group
  作者：Ye Yuan、Dou Guo、Yibo Liu、Congcong Wan、Dongbiao Lu、Hongxiang Yang、Yufan Lu、Wei Meng、Hongling Wang、Xiang Zhang

  DOI：10.1002/ejoc.202200387

  日期：2022.5.6

  An amido-directing regioselective and nucleophilic halogenation reaction of electron-rich amidophenols was realized in the presence of Fe(III) reagents. Halides could be sequentially introduced to specific positions to form mono-, di- and mixed di- halogenated amidophenols mostly in one-pot manner.

  在 Fe(III) 试剂的存在下，实现了富电子氨基酚的酰胺定向区域选择性和亲核卤化反应。卤化物可以依次引入特定位置以形成单卤代、二卤代和混合二卤代氨基酚，主要以一锅法的方式进行。
• 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles
  申请人：Tsubouchi Hidetsugu

  公开号：US20060094767A1

  公开（公告）日：2006-05-04

  The present invention provides a 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound represented by the following general formula: wherein R 1 represents a hydrogen atom or C1-C6 alkyl group, n represents an integer of 0 to 6, R 2 represents a group —OR 3 or the like, and R 3 represents a hydrogen atom, C1-C6 alkyl group or the like, or R 1 and —(CH 2 ) n R 2 may bind to each other together with carbon atoms adjacent thereto through nitrogen atoms so as to form a spiro ring represented by the general formula (H): wherein R 41 is hydrogen, C1-C6 alkyl group or the like. The present compound has an excellent bactericidal action against Mycobacterium tuberculosis , multi-drug-resistant Mycobacterium tuberculosis , and atypical acid-fast bacteria.

  本发明提供了一种2,3-二氢-6-硝基咪唑并[2,1-b]噁唑化合物，其通式如下：其中，R1代表氢原子或C1-C6烷基，n代表0到6的整数，R2代表—OR3或类似的基团，R3代表氢原子、C1-C6烷基或类似的基团，或者R1和—(CH2)nR2可以通过相邻的碳原子通过氮原子结合在一起形成一个螺环，其通式为（H）：其中，R41为氢、C1-C6烷基或类似的基团。该化合物对结核分枝杆菌、多药耐药结核分枝杆菌和非典型酸性快速细菌具有优异的杀菌作用。
• 4-氯-2-酰氨基酚的合成方法
  申请人：西北农林科技大学

  公开号：CN114380709B

  公开（公告）日：2023-07-21

  本发明涉及一种4‑氯‑2‑酰氨基酚的合成方法，2‑氨基酚与酰氯反应，生成2‑酰氨基酚类化合物；化合物与三个当量的三氯化铁在二氯甲烷加热条件回流下反应得到4‑氯‑2‑酰氨基酚类化合物。本发明合成原料易得，实验条件温和，避免了使用价格昂贵和高毒性的原料，操作安全，对环境污染小，收率较高，且可为IKKβ的一种选择性抑制剂IMD‑0354及中枢肌肉松弛剂氯唑沙宗(Chlorzoxazone)的合成提供新的方法。